← Back to headlines
Dr. Reddy's Biosimilar for Bristol's Orencia Undergoes FDA Review
Dr. Reddy's biosimilar for Bristol's Orencia is currently undergoing FDA review, marking a significant step in the development of new treatment options.
20 Feb, 16:40 — 20 Feb, 16:40
